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Background: Recently, a new subset of CD4+T helper cell termed Follicular helper T cells (Tfh), which play a pivotal
role in B cell activation and differentiation in lymphoid structures, has been reported to participate in some certain
autoimmune diseases. But whether Tfh cells are involved in the pathogenesis of VMC remains unclear.
Methods: Male BALB/c mice were intraperitoneally (i.p) infected with CVB3 to establish VMC models. Control mice
were treated with phosphate-buffered saline i.p. On 0, 1, 2, 3, 4, 6 weeks post injection, frequencies of splenic Tfh
cells were determined by flow cytometric analysis, productions of IL-21 and anti-adenine nucleotide translocator
(ANT) autoantibody were detected by enzyme-linked immunosorbent assay. To further investigate the effects of Tfh
cells, VMC mice were treated with Anti-IL-21 neutralizing antibody. Heart pathology was examined histologically, the
frequencies of Tfh cells and the expressions of anti-ANT autoantibody were investigated after anti-IL-21 intervention.
Spearman analysis was used to evaluate the relationship between the frequencies of Tfh cells and IL-21 levels with
anti-ANT autoantibody.
Results: The percentage of Tfh cells significantly increased in VMC mice from 1 W to 6 W, the serum level of IL-21
and ANT autoantibody were also significantly increased in VMC mice. Neutralization of IL-21 with anti-IL-21 can
ameliorate the myocardium inflammation, decrease Tfh cells and ANT autoantibody after IL-21 antibody intervention
compared with those of the control (P < 0.05). Both of the frequencies of Tfh cells and IL-21 levels were positively
correlated with anti-ANT antibody levels (R = 0.758, P < 0.05; R = 0.88, P < 0.01, respectively).
Conclusions: Those results suggest that Tfh cells and IL-21 might involve in the pathogenesis of VMC and play an
important role in anti-ANT autoantibody production. Targeting the Tfh cell and IL-21 may be a new therapeutic target
for the treatment of CVB3-induced VMC.
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Viral myocarditis(VMC) is an autoimmune disease and
often progresses to chronic myocarditis, dilated cardio-
myopathy (DCM) [1]. Excessive immune responses
(mediated especially by activated CD4+ T lymphocytes)
are the dominant causes of myocardial cell damage.
Humoural immune responses following VMC infection
are also significant in the pathogenesis of VMC infec-
tion. Current knowledge on the role of T responses in
the pathogenesis of myocarditis including T helper* Correspondence: whccu059@sina.com
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unless otherwise stated.(Th)1 [2,3], Th17 [4-7] and Th22 response [8]. What
more, assisting autoantibody, produced by activated
CD4+T cells is a fundamental respect of immune re-
sponses. Anti-β1-adrenergic receptor autoantibodies,
anti-adenine nucleotide translocator(ANT) autoanti-
bodies and anti-cardiac myosin autoantibodies were
common seen in VMC and DCM patients, suggesting
the existence of abnormal humoral autoimmune re-
sponses in VMC. Among these autoantibodies, anti-
ANT autoantibodies, whose antigenic determinant is
similar with Coxsackievirus B3 play a significant role in
the cardiac damages of viral myocarditis [9].his is an Open Access article distributed under the terms of the Creative
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CD4+T helper cells and one of the most significant sub-
sets of effector T cells in lymphoid tissues, have recently
emerged [10]. The major function of Tfh cells is to aid B
cells during GC reactions and antibody production dur-
ing humoral immune response [11]. Distinguishing fea-
tures of Tfh cells include CXC chemokine receptor 5
(CXCR5) expression, inducible co-stimulator (ICOS),
programmed death 1(PD-1), and the secretion of inter-
leukin (IL)-21(IL-21). IL-21, which stimulates B cells to
proliferation and differentiate into antibody-forming
cells via the IL-21 receptor, was a cytokine preferentially
excreted by Tfh cells [12,13]. Abnormal Tfh cells fre-
quency and regulation of Tfh cell function could con-
tributes to the pathogenesis of autoimmune-related
diseases [14]. Anti-ANT autoantibodies are related to
the development of Coxsackievirus B3 (CVB3)-triggered
VMC. However, little is known about the potential role
of Tfh cells and the relationship between Tfh cells with
Anti-ANT autoantibodies in VMC. Therefore, the
present study aimed to clarify whether Tfh cells involv-
ing in the pathogenesis of VMC and to determine
whether Tfh cells play an important role in pathogenic
anti-ANT autoantibody production in VMC. Besides, the
IL-21 monoclonal antibody (mAb) was given to VMCFigure 1 Elevated Tfh cells and IL-21 in VMC. A. Representative pictures
right quadrants indicate the mean percentages of Tfh cells in VMC mice. A
before analysis. B. The results of the Tfh cells statistical analysis. ▲P < 0.05, v
C. Transcription levels of IL-21 in myocardium. IL-21 mRNA transcripts were
control group. ■P <0.05, versus week 1, 2, 3, 4, and 6 VMC mice. ★P <0.05,
IL-21 protein levels were steadily increased in the VMC mice from 1 week afte
The highest level of IL-21 in VMC occurred on 2nd week. ▲P < 0.05, versus co
versus week 0, 2, 3 and 6 VMC mice.mice after CVB3 infection to investigate whether IL-21
is associated with the the production of anti-ANT auto-
antibodies in VMC mouse model.
Results
Increased Tfh cells and IL-21 in VMC mice
The percentages of Tfh cells in the spleens of VMC mice
and controls were analyzed by flow cytometry (FCM).
The percentages of CXCR5+ICOS+cells among the
CD4+T lymphocytes were used to represent the Tfh cells
(CXCR5+ICOS+CD4+). There was a significant increase
in the percentage of Tfh cells in the VMC mice as com-
pared with those of controls from the first week after
viral infection. Tfh cells frequencies in each subgroup of
VMC and control mice were 0.20 ± 0.11% vs 0.16 ± 0.02%
(0 W), 6.43 ± 3.05% vs 0.79 ± 0.50%(1 W), 13.44 ± 3.25%
vs 0.61 ± 0.07%(2 W), 9.96 ± 0.42% vs 0.57 ± 0.23%
(3 W), 8.58 ± 0.90% vs 0.56 ± 0.23%(4 W) and 7.07 ±
1.17% vs 0.52 ± 0.17%(6 W) [Figure 1A, B]. It becomes
clear that IL-21 produced by Tfh cells serve as an im-
portant regulator of humoral responses. Thus we de-
tected the IL-21 mRNA in the myocardium by RT-PCR
and protein levels in the serum by ELISA. IL-21 tran-
scripts were abundant in all samples from the first to the
sixth week in VMC mice [Figure 1C]. The highest levelof CXCR5+ICOS+CD4+ Tfh cells in VMC mice. Numbers in the upper
ll staining samples were restimulated with PMA/ionomycin for 4 h
ersus control group. ΔP < 0.01, versus week 0, 1, 3, 4, and 6 VMC mice.
higher, in the VMC group than in the PBS group. ▲P < 0.05, versus
versus week 0, 3, 4, and 6 VMC mice. D. IL-21 protein levels in serum.
r i.p, and reached statistical difference comparing with those of controls.
ntrol group. ■P <0.05, versus week 1, 2, 3, 4, and 6 VMC mice, ★P <0.05,
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were 1.04 ± 0.22, 3.25 ± 0.26, 4.01 ± 0.98, 2.73 ± 0.32, 2.02 ±
0.41 and 2.16 ± 0.39 times higher respectively in the VMC
group than in the PBS group. There was a significant in-
crease of IL-21 protein levels in VMC mice as compared
with those in the PBS controls from the 1st week to 6th
week. The highest level was reached on 2nd week. The
IL-21 protein levels at different times in VMC and
control mice were 13.73 ± 0.75 vs 13.07 ± 0.96 pg/ml,
101.81 ± 14.01 vs 13.02 ± 1.14 pg/ml, 119.84 ± 12.46 vs
22.21 ± 6.26 pg/ml, 111.37 ± 1.90 vs 34.08 ± 4.44 pg/ml,
97.54 ± 12.14 vs 30.29 ± 18.64 pg/ml and 82.61 ± 8.78 vs
36.20 ± 6.23 pg/ml respectively [Figure 1D].Increased levels of anti-ANT autoantibody in VMC mice
From the first week, anti-ANT autoantibody levels in the
serum began increasing in a stable manner, peaking on
the second week, and possessing high expression till the
sixth week [Figure 2]. The anti-ANT autoantibody levels
at different times in VMC and control mice were 2.93 ±
0.68 vs 2.94 ± 0.29 pg/ml, 6.51 ± 1.21 vs 2.89 ± 0.41 pg/ml,
9.15 ± 0.95 vs 2.66 ± 1.37 pg/ml, 6.27 ± 0.71 VS 2.71 ±
0.11 pg/ml, 6.35 ± 1.40 vs 2.83 ± 0.14 pg/ml and 5.57 ±
2.20 vs 2.94 ± 0.10 pg/ml separately. Significant statistics
difference were seen when comparing anti-ANT autoanti-
body between VMC and control group except 0 week
(P > 0.05).IL-21mAb alleviated the severity of myocarditis
The number of mice who survived to 14d was 6, 6, 3
and 4 for normal, IL-21mAb, isotype control and PBS
groups separately. All survival mice were sacrificed on
the day 14th after intervention. Histological results
showed that IL-21mAb alleviated the severity ofFigure 2 Anti-ANT autoantibody levels increased in the serum
of VMC mice. ▲P < 0.05, versus control group. ◆P <0.05, versus
week 1, 2, 3, 4, and 6 VMC mice, ★P <0.05, versus week 0, 2, 3 and
6 VMC mice.myocarditis. The pathological scores of IL-21mAb mice
were much lower than isotype control-treated and PBS
mice [Figure 3]. The pathological scores of IL-21mAb
group mice were slightly higher than those in the normal
group, but no statistical difference was seen between
them (P > 0.05). However, there was no significant dif-
ference of the pathological scores of heart section be-
tween the isotype antibody-treated groups and PBS
groups (P > 0.05).Blockade of IL-21 reduced Tfh cell proportions and
circulating level of anti-ANT autoantibodies
Compared with those in the normal group, the percent-
ages of Tfh cells in the IL-21 mAb, isotype control and
PBS groups increased markedly (P < 0.05) [Figure 4A, B].
The proportion of Tfh cells in the IL-21 mAb group
trended lower than that of the isotype control and PBS
groups, there was significant difference among them
(P < 0.05) [Figure 4B]. Tfh frequencies in the IL-21
mAb, isotype control, PBS group and normal were
5.45 ± 0.97%, 11.47 ± 2.57%, 11.11 ± 1.04% and 1.13 ±
0.19% respectively. The levels of serum anti-ANT auto-
antibody levels in the IL-21 mAb, isotype control and
PBS groups were elevated dramatically, compared with
those in the normal group, especially in the isotype
control and PBS groups [Figure 4C]. The levels of
serum anti-ANT autoantibody in the normal group,
IL-21 mAb, isotype control and PBS and were 2.89 ±
0.41 pg/ml, 4.15 ± 0.45 pg/ml, 9.15 ± 0.95 pg/ml, 9.01 ±
0.86 pg/ml. Statistical difference were seen when com-
pared the levels of Anti-ANT antibody among these
four groups, P < 0.05. The levels of serum anti-ANT
autoantibody in the IL-21 mAb group were much
lower than those in the isotype control and PBS groups
(P < 0.05) [Figure 4C], which indicated that blockade of
IL-21 can reduced circulating level of anti-ANT auto-
antibodies. No significant difference was seen between
the isotype control group and PBS group (P > 0.05).Positive correlation of Tfh cell proportions and IL-21 with
levels of Anti-ANT autoantibody
FCM results suggested that Tfh cells and IL-21 increased
in VMC mice, and blockade of IL-21 reduced Tfh cell
proportions. Thus, we then analyzed the relationship be-
tween the anti-ANT autoantibody titers with the per-
centages of Tfh cells and IL-21 level. The percentages of
CXCR5+ICOS+CD4+T lymphocytes showed a positive cor-
relation with the anti-ANT autoantibody titers (r = 0.758,
P < 0.05) [Figure 5A]. The correlation between the level of
IL-21 and the anti-ANT antibody titers was also analyzed,
and a similarly positive correlation was observed (r = 0.88,
P < 0.01) [Figure 5B].
Figure 3 The pathological scores attenuated after IL-21 inhibition. Each point represents an individual mouse, *P <0.05, versus isotype
control group mice, △P <0.05, versus PBS group mice.
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Although VMC has appeared to be a T-cell-mediated
autoimmune disease over the past few decades, Neither
Th1, Th2 nor Th17 could elucidate the pathogenesis of
VMC completely. Besides, high levels of circulating
autoantibodies, such as anti-β1-adrenergic receptor
autoantibodies, anti- ANT autoantibodies, and anti-
cardiac myosin autoantibodies produced by B cells sug-
gested that B cells are also correlated with theFigure 4 Tfh cell proportions and circulating level of anti-ANT autoan
cells in each groups investigated by flow cytometry. Tfh subsets were gate
represents an average number of positive cells in each group. All staining s
B. The results of the Tfh cells statistical analysis. The percentages of Tfh cell
versus normal group. ★P < 0.05, versus isotype control mice. ◆P < 0.05, versu
groups. ▲P < 0.05, versus normal group. ★P < 0.05, versus isotype control mdevelopment and severity of the VMC [9,15,16]. Previous
researches presumed that Th2 cells may play a crucial
role in B cell-mediated humoural immune responses.
Tfh cells, a new separate CD4+ T helper lineage, have
attracted close attention for their specialized role in
assisting B cells and contributing to autoimmunity
[10,17,18]. Tfh cells could provide costimulation signal
to promote growth, differentiation, and class switching
of B cells and lead to excessive autoantibody productiontibodies decreased after IL-21 inhibition. A. The percentages of Tfh
d with CXCR5+ICOS+/CD4+ cells. Numbers in upper right quadrants
amples were restimulated with PMA/ionomycin for 4 h before analysis.
s in IL-21mAb group was fewer than control and PBS group. ▲P < 0.05,
s PBS group mice. C. Anti-ANT autoantibody levels in the different
ice. ◆P <0.05, versus PBS group mice.
Figure 5 Aberrant CXCR5+ICOS+/CD4+ cells proportions and IL-21 correlated with anti-ANT autoantibody titers in VMC mice. A. The
correlation between percentages of CXCR5+ICOS+/CD4+ cells with anti-ANT autoantibody in VMC mice. B. The correlation between levels of IL-21
with anti-ANT autoantibody titers in VMC mice. Spearman correlation was applied to depict linear relationships. Each data point represents an
individual subject.
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such as ICOS and CD40L. In addition, IL-21, which
preferentially produced by Tfh cells and served as an im-
portant regulator of humoral responses, could drive B
cell expansion and differentiation. Abnormal distribution
and frequency of Tfh cells are associated with the patho-
genesis of systemic lupus erythematosus (SLE) [19-21],
rheumatoid arthritis [22,23], Sjögren syndrome [24,25]
and other autoimmune diseases [26,27]. Besides, evi-
dence has shown that excessive production of IL-21 led
to autoimmunity [28,29]. However, their association with
VMC remains largely unknown.
Anti-ANT autoantibody is a cross-reacting antibody
against ANT at the inner mitochondrial membrane of
myocardium, whose antigenic determinants are similar
with those of CVB3 [27]. High titer of this autoantibody
has been recognized as a marker of the severity and the
activity of the VMC [27]. The present study aimed to de-
termine whether Tfh cells play a pathogenic role in
VMC and to clarify their involvement in the anti-ANT
autoantibodies production of VMC. The increased fre-
quency of Tfh cells and level of IL-21 were detected in
VMC mice induced by CVB3. These results indicated
the possible involvement of Tfh cells and IL-21 in the
pathogenesis of VMC. More importantly, inhibition of
aberrant circulating IL-21 by neutralizing Ab can de-
creased the proportion of Tfh cells and levels of anti-
ANT autoantibodies. These are in agreement with the
studies of Tfh cells are related to autoantibody produc-
tion in other autoimmune diseases [30,31]. Consistent
with these data, we describe here that Tfh cells and IL-
21 concentration have a significantly positive correlation
with anti-ANT autoantibody level. These data also indi-
cated that IL-21 is a promoting factor in the differenti-
ation/expansion of Tfh cells, and antibody production,
in murine model of VMC. Our research showed that
blocking IL-21 signaling pathway in VMC mice led toattenuate inflammation of myocardium and production
of pathogenic anti-ANT autoantibody, which indicates
that IL-21 pathway might be a potential treatment for
VMC.
However, it is worth noting that IL-21 are also
expressed by Th17 cells [32,33]. Thus, the finding of in-
creased IL-21 is not exact proof of Tfh activation but
could also be a result of Th17 activity. Yet it were Tfh
cells but not Th17 cells might be the main producer of
IL-21 that contribute to the VMC processes, as the time
course of Th17 cells do not coincidence with that of IL-
21 [4]. In addition, Studies have disclosed a subset with
a overlapping features of Tfh -cells [11,34], named
Th17-like Tfh cell. To deplete the contribution of Th17-
like Tfh subsets in VMC evolvement, spleen Th17-like
Tfh cell subsets were defined by multicolor flow cytome-
try (CD4+ICOS+CCR6+). No significant difference of
Th17-like Tfh frequency was observed in VMC mice
compared to control individuals (data unpublished).
Conclusion
Taken together, our results indicated that Tfh cells were
involved in the pathogenesis of VMC and that they may
play a role in the production of pathogenic anti-ANT
autoantibodies. Meanwhile, blockade of IL-21 can inhibit
Tfh cell and anti-ANT autoantibody secretion in vivo.
As exact causality between Tfh cells and anti-ANT auto-
antibody have not clarified. Further studies are needed
to determine how Tfh cells initiate anti-ANT autoanti-
body production in VMC and to clarify the mechanisms
involved.
Materials and methods
Mice and ethics statement
Four-week-old SPF male BALB/c mice were obtained
from Shanghai Laboratory Animal Center, Chinese
Academy of Sciences. All animals were housed under
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Center of the Guangxi Medical University. Experiments
using mice were performed in accordance with protocols
approved by Guangxi Medical University Animal Ethics
Committee.
CVB3 titration and myocarditis induced
Heart-passaged CVB3 (Nancy strain) was propagated in
Hep-2 cells, the 50% tissue culture infectious dose
(TCID50) titer was determined by the cytopathic effects
visible after 72 h. The TCID50 assay result for Hep-2
cells was 1 × 10−7. BALB/c mice were infected by intra-
peritoneal (i.p.) injection of 0.1 ml of PBS containing ap-
proximately 100TCID50 of the virus (VMC group n = 60,
10 mice/subgroup) or inoculated i.p. with PBS(control
group, n = 60, 10 mice/subgroup). Each group was di-
vided into 6 subgroups (Week 0, 1, 2, 3, 4 and 6). The
day of injection was defined as week 0. Surviving mice
of 6 subgroups were separately sacrificed by cervical dis-
location on 0, 1, 2, 3, 4, and 6 weeks after i.p. injection.
Histopathology
The ventricular tissues of the hearts were cut longitudin-
ally, fixed in 10% formalin, then embedded in paraffin,
and stained with hematoxylin & eosin, histopathological
change was observed by using light microscopy (Nikon
Eclipse E800 Microscope, Kawasaki, Kanagawa, Japan).
Pathological scores were graded by two independent pa-
thologists separately in a blinded manner based on the
following semi-quantitative scale: 0, no inflammatory in-
filtrates; 1, small foci of inflammatory cells between
myocytes or inflammatory cells surrounding individual
myocytes; 2, larger foci of 100 inflammatory cells or in-
volving at least 30 myocytes; 3, 10% of a myocardial
cross-section involved; 4, 30% of a myocardial cross-
section involved [35].
Lymphocyte preparation
Spleens from virus-infected mice and controls were har-
vested aseptically. The lymphocyte fractions of these
samples were obtained by Ficoll Plaque (Solarbio Science
& Technology, China) gradient centrifugation. Lympho-
cytes were maintained in a 24-well flat-bottom tissue
culture plate with RPMI 1640 supplemented with 10%
fetal calf serum (Gibco, USA) at 37°C in a humidified at-
mosphere with 5% CO2.
Flow cytometry
Lymphocytes at 106/tube were stained with fluorescein
isothiocyanate (FITC)-conjugated anti-CD4, phycoeryth-
rin (PE)-conjugated anti-CXCR5, phycoerythrin-Cy5
(PE-Cy5)-conjugated anti-ICOS (BD PharMingen San
Diego, CA) or isotype-matched control IgG, according
to the manufacturer’s protocol and fixed in 4%paraformaldehyde. Flow data were analyzed on a FACS
Calibur flow cytometer (BD Biosciences). CellQuest soft-
ware (BD Biosciences) was used for data acquisition. At
least 50,000 events per sample were analyzed. Cells were
gated on the forward scatter of living cells and then cen-
tered on CD4+T cells. After setting the threshold using
isotype control staining for CXCR5 and ICOS, the pro-
portion of Tfh cells was analyzed as the percentage of
CXCR5+ICOS+cells within total CD4+T cells for each
sample, and percentages of CXCR5+ICOS+/CD4+cells
proportion was defined as Tfh cells.
Real-time RT–PCR
Total RNA including the small RNA fraction of homog-
enized heart tissues was extracted with TRIZOL
Reagent® (Invitrogen, USA), and then reverse tran-
scripted into cDNA with an Reverse Transcription kit
(Ferma, CA) according to the manufacturer’s instruc-
tions. Primer for IL-21 and the housekeeping gene
GAPDH are designed by Primer Premier 5.0. Real time-
polymerase chain reaction (RT-PCR) was performed
using an ABI 7500 Sequence Detection System (Applied
Biosystems, Foster City, CA) using SYBR green. The
amplification steps consisted of denaturation at 95°C,
followed by 40 cycles of denaturation at 95°C for 15 s
and then annealing at 60°C for 1 min. The relative gene
expressions were normalized to the level of GAPDH
transcripts and quantified by the ΔΔCT method using
7500 System Sequence Detection software (Applied Bio-
systems). All reactions were performed in at least tripli-
cate for each sample.
Cytokine assay
Blood was collected via retro-orbital bleeding, and
serum was separated. The amounts of IL-21 and ANT
autoantibody in the blood serum were detected using
the Quantikine Mouse IL-21 (R&D Systems, Minneapolis,
MN) and ANT Immunoassay (CUSABIO, China). No
cross-reactivity was observed in detection. All samples
were measured in triplicate.
Interventions and groups
Mice infected with CVB3 (VMC mice) were separated
into three groups: administered either IL-21mAb
(100 μg per mouse, eBioscience, IL-21 mAb group, n = 6),
isotype control immuno-globulin (Ig) G1Ab (100 μg per
mouse, eBioscience, isotype control group, n = 6), or PBS
(PBS group, n = 6) i.p. at day 0,4,7 and 10 after CVB3 in-
fection. In addition, BALB/c mice without any interven-
tion were assigned as the normal control (normal group,
n = 6). All animals were killed on day 14 after virus infec-
tion. The values of the pathological scores were recorded.
The percentages of CXCR5+ICOS+/CD4+cells proportion
Yang et al. Virology Journal  (2015) 12:20 Page 7 of 7and the amounts of anti-ANT autoantibody in the blood
serum were recorded at the same time.
Statistical analysis
Data were shown as the mean ± SD. Statistical analysis
of the data was performed with one-way ANOVA using
SPSS17.0. Bivariate correlation was used as a test of cor-
relation between two variables, P < 0.05 was considered
statistically significant.
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